| Mrs Angela N Katzfuss, PHARMD | |
|
1028 Horicon St, Mayville, WI 53050-1429 | |
| (920) 387-7800 | |
| Not Available |
| Full Name | Mrs Angela N Katzfuss |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1028 Horicon St, Mayville, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053576041 | NPI | - | NPPES |
| 33184600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14720-040 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Angela N Katzfuss, PHARMD 1028 Horicon St, Mayville, WI 53050-1429 Ph: (920) 387-7800 | Mrs Angela N Katzfuss, PHARMD 1028 Horicon St, Mayville, WI 53050-1429 Ph: (920) 387-7800 |
News Archive
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today it has entered into a distribution agreement for Lymphoseek (technetium Tc 99m tilmanocept) Injection in Taiwan with Global Medical Solutions Taiwan, Ltd., a leading in-country distributor of nuclear medicine and diagnostic imaging products.
Scientists at Baylor College of Medicine, Baylor Genetics, the University of Texas Health Science Center at Houston and Texas Children's Hospital are combining descriptions of patients' clinical features with their complex genetic information in a unified analysis to obtain more precise diagnoses of complex diseases, particularly those that involve more than one gene causing the condition.
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Several hundred internists and medical students were on Capitol Hill Thursday, meeting with their members of Congress to advocate for issues facing internal medicine.
The Burzynski Research Institute, Inc. (BRI) today announced that it has signed a Research Agreement with the UAB Division of Preventive Medicine, Biostatistics and Bioinformatics Shared Facility (BBSF) that will provide biostatistical and data management support for BRI's ongoing Phase II and Phase III protocol studies of Antineoplaston (ANP) treatment for gliomas.
› Verified 3 days ago
Lynne Ann Dittman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1028 Horicon St, Mayville, WI 53050 Phone: 920-387-7800 Fax: 920-387-7809 | |
Dr. Staci Marie Williams, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1028 Horicon St, Mayville, WI 53050 Phone: 920-387-7800 Fax: 920-387-7809 | |
Erin Williams, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1448 Horicon St, Mayville, WI 53050 Phone: 920-644-2080 Fax: 920-644-2208 | |
Erica Elaine Rodd, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1028 Horicon St, Mayville, WI 53050 Phone: 920-387-7800 Fax: 920-387-7809 | |
Jessica Nellie Wolf, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1028 Horicon St, Mayville, WI 53050 Phone: 920-387-7800 Fax: 920-387-7809 | |
Amy Karin Kulig, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2050 Horicon St, Mayville, WI 53050 Phone: 920-387-0257 Fax: 920-387-0272 |